Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: RT who wrote (4313)	1/4/1998 9:45:00 PM
From: blankmind	Respond to of 23519

-- RT, the average investing novice can be mislead by insider buying and selling patters. -- As the Wall Street Journal has pointed out on many occasions, there is no correlation between insider buying and selling. -- The CFO's 40,000 remaining shares represents about $400,000. Maybe he's worth $1 mill. If you ask me, as a CPA and financial adviser, he's still too concentrated in Vivus stock and could sell another 20,000 shares. -- Also, could you show the URL (bookmark) for the site that shows insider ownership? As I seem to have lost it. Thanks.

To: RT who wrote (4313)	1/5/1998 4:53:00 AM
From: Whipsaw	Read Replies (1) \| Respond to of 23519

RT, re CFO sales: << I see he sold 15,000 shares on 11/21/97 @$24.82 and 15,000 shares on 10/31/97 @ $35.63 leaving him with 39,722 shares.>> What is your source for this? Does your source specifically name the Vivus CFO, David Yntema, or just use a key letter (which is not 100% reliable) to indicate sales by someone in a CFO-like position? (A while back there was discussion on this thread about Julian Gangoli, the VP of Marketing, selling some shares. Some folks may have gotten him mixed up with the CFO.)